Aura Biosciences, Inc.
AURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $408,127 | $351,033 | $314,341 | $496,014 |
| - Cash | $31,693 | $41,063 | $121,582 | $149,063 |
| + Debt | $18,769 | $19,557 | $20,858 | $975 |
| Enterprise Value | $395,203 | $329,527 | $213,617 | $347,926 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$1,295 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$94,893 | -$83,696 | -$59,118 | -$34,419 |
| % Margin | – | – | – | – |
| Net Income | -$86,919 | -$76,408 | -$58,763 | -$35,251 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.75 | -1.93 | -1.96 | -1.58 |
| % Growth | 9.3% | 1.5% | -24.1% | – |
| Operating Cash Flow | -$79,805 | -$63,847 | -$54,601 | -$32,410 |
| Capital Expenditures | -$1,253 | -$709 | -$1,094 | -$2,125 |
| Free Cash Flow | -$81,058 | -$64,556 | -$55,695 | -$34,535 |